(HIES) has begun operating a next-generation power conditioner (1) called a Grid Forming Inverter (GFM), at its Narashino ...

The Human Capability Development Program (HCDP), started in 2021 as part of Saudi Arabia's Vision 2030, intends to empower ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) ...

PerfectSwell Zion - A world class surf venue featuring cutting-edge 6th generation PerfectSwell® technology and the most innovative wave package to date. PerfectSwell® is patented, proven and reliable ...

金嗓子集团（06896.HK）凭借过硬的技术壁垒与深厚的品牌积淀，稳居行业龙头地位。近期，金嗓子集团公布2024年业绩，期内，营收同比增长23.3%至人民币11.85亿元，权益持有人应占溢利同比27.3%至人民币3.19亿元。

得益於經營發展的持續向好，金嗓子股價2025年以來累計升幅逾20%，顯著跑贏恒生醫療保健指數，印證資本市場對其成長邏輯的認可。事實上，公司股價已強勢多年，4月3日最高升至4.20港元，創2016年10月份以來新高。